EZH2 inhibtion and IFNy treatment of patient derived organoids [RNA-seq]
We report the transcriptomics of squamous lung cancer patient derived tumoroids treated with EZH2 inhibitor and IFNy Overall design: To determine that EZH2 inhibition and IFNy upregulate genes involved in antigen presentation machinery and immunogenicity